Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Denosumab Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 60 mg
1.2.3 120 mg
1.3 Market by Application
1.3.1 Global Denosumab Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Denosumab Market Perspective (2018-2033)
2.2 Denosumab Growth Trends by Region
2.2.1 Global Denosumab Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Denosumab Historic Market Size by Region (2018-2023)
2.2.3 Denosumab Forecasted Market Size by Region (2024-2033)
2.3 Denosumab Market Dynamics
2.3.1 Denosumab Industry Trends
2.3.2 Denosumab Market Drivers
2.3.3 Denosumab Market Challenges
2.3.4 Denosumab Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Denosumab Players by Revenue
3.1.1 Global Top Denosumab Players by Revenue (2018-2023)
3.1.2 Global Denosumab Revenue Market Share by Players (2018-2023)
3.2 Global Denosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Denosumab Revenue
3.4 Global Denosumab Market Concentration Ratio
3.4.1 Global Denosumab Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Denosumab Revenue in 2022
3.5 Denosumab Key Players Head office and Area Served
3.6 Key Players Denosumab Product Solution and Service
3.7 Date of Enter into Denosumab Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Denosumab Breakdown Data by Type
4.1 Global Denosumab Historic Market Size by Type (2018-2023)
4.2 Global Denosumab Forecasted Market Size by Type (2024-2033)
5 Denosumab Breakdown Data by Application
5.1 Global Denosumab Historic Market Size by Application (2018-2023)
5.2 Global Denosumab Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Denosumab Market Size (2018-2033)
6.2 North America Denosumab Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Denosumab Market Size by Country (2018-2023)
6.4 North America Denosumab Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Denosumab Market Size (2018-2033)
7.2 Europe Denosumab Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Denosumab Market Size by Country (2018-2023)
7.4 Europe Denosumab Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Denosumab Market Size (2018-2033)
8.2 Asia-Pacific Denosumab Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Denosumab Market Size by Region (2018-2023)
8.4 Asia-Pacific Denosumab Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Denosumab Market Size (2018-2033)
9.2 Latin America Denosumab Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Denosumab Market Size by Country (2018-2023)
9.4 Latin America Denosumab Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Denosumab Market Size (2018-2033)
10.2 Middle East & Africa Denosumab Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Denosumab Market Size by Country (2018-2023)
10.4 Middle East & Africa Denosumab Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Denosumab Introduction
11.1.4 Amgen Revenue in Denosumab Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Company Detail
11.2.2 Qilu Pharmaceutical Business Overview
11.2.3 Qilu Pharmaceutical Denosumab Introduction
11.2.4 Qilu Pharmaceutical Revenue in Denosumab Business (2018-2023)
11.2.5 Qilu Pharmaceutical Recent Development
11.3 Shandong Boan Biotech
11.3.1 Shandong Boan Biotech Company Detail
11.3.2 Shandong Boan Biotech Business Overview
11.3.3 Shandong Boan Biotech Denosumab Introduction
11.3.4 Shandong Boan Biotech Revenue in Denosumab Business (2018-2023)
11.3.5 Shandong Boan Biotech Recent Development
11.4 Shanghai Mabwell
11.4.1 Shanghai Mabwell Company Detail
11.4.2 Shanghai Mabwell Business Overview
11.4.3 Shanghai Mabwell Denosumab Introduction
11.4.4 Shanghai Mabwell Revenue in Denosumab Business (2018-2023)
11.4.5 Shanghai Mabwell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Denosumab Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of 60 mg
Table 3. Key Players of 120 mg
Table 4. Global Denosumab Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Denosumab Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Denosumab Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Denosumab Market Share by Region (2018-2023)
Table 8. Global Denosumab Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Denosumab Market Share by Region (2024-2033)
Table 10. Denosumab Market Trends
Table 11. Denosumab Market Drivers
Table 12. Denosumab Market Challenges
Table 13. Denosumab Market Restraints
Table 14. Global Denosumab Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Denosumab Market Share by Players (2018-2023)
Table 16. Global Top Denosumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Denosumab as of 2022)
Table 17. Ranking of Global Top Denosumab Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Denosumab Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Denosumab Product Solution and Service
Table 21. Date of Enter into Denosumab Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Denosumab Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Denosumab Revenue Market Share by Type (2018-2023)
Table 25. Global Denosumab Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Denosumab Revenue Market Share by Type (2024-2033)
Table 27. Global Denosumab Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Denosumab Revenue Market Share by Application (2018-2023)
Table 29. Global Denosumab Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Denosumab Revenue Market Share by Application (2024-2033)
Table 31. North America Denosumab Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Denosumab Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Denosumab Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Denosumab Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Denosumab Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Denosumab Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Denosumab Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Denosumab Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Denosumab Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Denosumab Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Denosumab Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Denosumab Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Denosumab Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Denosumab Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Denosumab Market Size by Country (2024-2033) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Denosumab Product
Table 49. Amgen Revenue in Denosumab Business (2018-2023) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Qilu Pharmaceutical Company Detail
Table 52. Qilu Pharmaceutical Business Overview
Table 53. Qilu Pharmaceutical Denosumab Product
Table 54. Qilu Pharmaceutical Revenue in Denosumab Business (2018-2023) & (US$ Million)
Table 55. Qilu Pharmaceutical Recent Development
Table 56. Shandong Boan Biotech Company Detail
Table 57. Shandong Boan Biotech Business Overview
Table 58. Shandong Boan Biotech Denosumab Product
Table 59. Shandong Boan Biotech Revenue in Denosumab Business (2018-2023) & (US$ Million)
Table 60. Shandong Boan Biotech Recent Development
Table 61. Shanghai Mabwell Company Detail
Table 62. Shanghai Mabwell Business Overview
Table 63. Shanghai Mabwell Denosumab Product
Table 64. Shanghai Mabwell Revenue in Denosumab Business (2018-2023) & (US$ Million)
Table 65. Shanghai Mabwell Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Denosumab Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Denosumab Market Share by Type: 2022 VS 2033
Figure 3. 60 mg Features
Figure 4. 120 mg Features
Figure 5. Global Denosumab Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Denosumab Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Denosumab Report Years Considered
Figure 11. Global Denosumab Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Denosumab Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Denosumab Market Share by Region: 2022 VS 2033
Figure 14. Global Denosumab Market Share by Players in 2022
Figure 15. Global Top Denosumab Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Denosumab as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Denosumab Revenue in 2022
Figure 17. North America Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Denosumab Market Share by Country (2018-2033)
Figure 19. United States Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Denosumab Market Share by Country (2018-2033)
Figure 23. Germany Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Denosumab Market Share by Region (2018-2033)
Figure 31. China Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Denosumab Market Share by Country (2018-2033)
Figure 39. Mexico Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Denosumab Market Share by Country (2018-2033)
Figure 43. Turkey Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Denosumab Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Denosumab Business (2018-2023)
Figure 46. Qilu Pharmaceutical Revenue Growth Rate in Denosumab Business (2018-2023)
Figure 47. Shandong Boan Biotech Revenue Growth Rate in Denosumab Business (2018-2023)
Figure 48. Shanghai Mabwell Revenue Growth Rate in Denosumab Business (2018-2023)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed